Istodax Approved for Cutaneous T-Cell Lymphoma

Full story: WOIO

The Gloucester Pharmaceuticals drug Istodax has been approved by the U.S. Food and Drug Administration to treat cutaneous T-cell lymphoma in people who have tried at least one prior systemic therapy, the drug's manufacturer said in a news release.

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Lymphoma Discussions

Topic	Updated	Last By	Comments
Innovative Strategies Improve Outcomes and Redu...	9 hr	Privatization	1
Questioning a $30,000-a-Month Cancer Drug	Dec 6	Phil	1
Pastor, author Billy Joe Daugherty, 57, dies af...	Dec 5	Eugene	9
Pastor, author Billy Joe Daugherty, 57, dies af...	Dec 1	Janice	11
Details On The Cancer That Claimed The Life Of ...	Nov 30	Juliana	12
Tulsa Pastor Diagnosed With Cancer	Nov 30	Sista	71
VA adds three more diseases to Agent Orange 'pr...	Nov 21	Carl Young	12